经皮左心耳封堵 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure
Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants: A Nationwide Propensity Score–Weighted Study
Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion
Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry

Consensus

Volume 76, Issue 5, August 2020

JOURNAL：J Am Coll Cardiol.

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

GF Tomaselli, KW Mahaffey, A Cuker et al.

3445

Keywords: ACC Expert Consensus Decision Pathway; apixaban; atrial fibrillation; betrixaban; dabigatran; edoxaban; rivaroxaban; venous thromboembolism; warfarin

Full Text PDF